Latigo Biotherapeutics Challenges Vertex With Positive Phase 2 Pain Data

By Jonathan Wosen · STAT News · 2026-07-29

According to STAT News, Latigo Biotherapeutics has released mid-stage clinical results for its oral pain treatment, LTG-001. The trial focused on 343 patients recovering from abdominoplasty, measuring the drug’s ability to provide relief without the use of habit-forming substance

According to STAT News, Latigo Biotherapeutics has released mid-stage clinical results for its oral pain treatment, LTG-001. The trial focused on 343 patients recovering from abdominoplasty, measuring the drug’s ability to provide relief without the use of habit-forming substance